Search results for "Prostate cancer"


 
Results 51 - 60 of about 117 for "Prostate cancer".
Sort by: Relevance | Newest | Oldest

Dealing with dementia, Q&As on COVID-19

This issue also covers testosterone and men's health, as well as preconception care.
https://immattersacp.org/archives/2020/05/dealing-with-dementia-qandas-on-covid-19.htm
1 May 2020

NAFLD treatment starts with weight loss, then other modes

Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016

Information plus documentation a must for informed consent

Documentation of informed consent is an important deterrent to malpractice and negligence claims. One physician describes how his informed consent process was the deciding factor in a missed case of prostate cancer, and outlines how any physician can accomplish it.
https://immattersacp.org/archives/2012/01/consent.htm
1 Jan 2012

MKSAP Quiz: Exacerbations of heart failure

A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018

Decision aids integral to shared decision making

When used properly and in the correct situation, decision aids save time and costs by better meeting patient needs and increasing adherence.
https://immattersacp.org/archives/2019/05/decision-aids-integral-to-shared-decision-making.htm
1 May 2019

Task Force draft recommendation leaves PSA screening choice up to patients

Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
https://immattersacp.org/weekly/archives/2017/04/18/1.htm
18 Apr 2017

Look for reasons if patients refuse advice

Refusal can be frustrating for physicians, who likely see their medical advice as contributing toward healing and improving quality of life. But patients reserve the right to make informed decisions about their care, even if these decisions run counter to what's been recommended.
https://immattersacp.org/archives/2014/02/informed-refusal.htm
1 Feb 2014

PSA screening halves cancer mortality

Cancer diagnoses often given quickly, impersonallyEmail improved care for diabetics
https://immattersacp.org/weekly/archives/2010/07/13/4.htm
13 Jul 2010

ACP convenes, in person and virtually, for Internal Medicine Meeting 2022

This month's issue considers coverage of Internal Medicine Meeting 2022, Leadership Day in Washington, D.C., and ACP's ninth COVID-19 forum.
https://immattersacp.org/archives/2022/07/acp-convenes-in-person-and-virtually-for-internal-medicine-meeting-2022.htm
1 Jul 2022

Research model supports strategies that increase PSA screening interval and age-specific thresholds for biopsy

Using higher thresholds for biopsy referral for older men and screening men with initially low prostate-specific antigen (PSA) levels less frequently seem to reduce harms of screening while preserving lives, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/5.htm
5 Feb 2013

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next